Lawrence Keusch

Stock Analyst at Raymond James

(2.59)
# 2,128
Out of 4,847 analysts
97
Total ratings
60.87%
Success rate
7.92%
Average return

Stocks Rated by Lawrence Keusch

Becton, Dickinson and Company
Aug 4, 2023
Maintains: Outperform
Price Target: $305$304
Current: $170.66
Upside: +78.13%
Zimmer Biomet Holdings
May 5, 2021
Maintains: Strong Buy
Price Target: $187$200
Current: $91.85
Upside: +117.75%
Avantor
Apr 29, 2021
Maintains: Outperform
Price Target: $34$37
Current: $13.15
Upside: +181.37%
Stryker
Apr 28, 2021
Maintains: Outperform
Price Target: $255$290
Current: $381.01
Upside: -23.89%
Teleflex
Mar 12, 2021
Maintains: Strong Buy
Price Target: $460$480
Current: $121.44
Upside: +295.26%
The Cooper Companies
Mar 5, 2021
Maintains: Outperform
Price Target: $94$104
Current: $66.91
Upside: +55.06%
Haemonetics
Feb 12, 2021
Maintains: Outperform
Price Target: $145$155
Current: $69.66
Upside: +122.51%
Baxter International
Feb 5, 2021
Maintains: Outperform
Price Target: $88$85
Current: $30.09
Upside: +182.49%
Masimo
Jan 29, 2021
Maintains: Outperform
Price Target: $275$285
Current: $164.06
Upside: +73.72%
Intuitive Surgical
Jan 22, 2021
Maintains: Outperform
Price Target: $267$288
Current: $551.85
Upside: -47.75%
Downgrades: Market Perform
Price Target: n/a
Current: $243.33
Upside: -